| Intratumor heterogeneity: nature and biological significance TS Gerashchenko, EV Denisov, NV Litviakov, MV Zavyalova, ... Biochemistry (Moscow) 78 (11), 1201-1215, 2013 | 164* | 2013 |
| Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response NV Litviakov, NV Cherdyntseva, MM Tsyganov, EV Denisov, EY Garbukov, ... Cancer Chemotherapy and Pharmacology 71 (1), 153-163, 2013 | 89 | 2013 |
| The presence of alveolar structures in invasive ductal NOS breast carcinoma is associated with lymph node metastasis MV Zavyalova, VM Perelmuter, SV Vtorushin, EV Denisov, NV Litviakov, ... Diagnostic Cytopathology, doi: 10.1002/dc.21852, 2011 | 71 | 2011 |
| Intratumoral morphological heterogeneity of breast cancer: neoadjuvant chemotherapy efficiency and multidrug resistance gene expression EV Denisov, NV Litviakov, MV Zavyalova, VM Perelmuter, SV Vtorushin, ... Scientific reports 4 (1), 4709, 2014 | 69 | 2014 |
| Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant … T Liu, I Larionova, N Litviakov, V Riabov, M Zavyalova, M Tsyganov, ... Oncoimmunology 7 (6), e1436922, 2018 | 67 | 2018 |
| Natural and chemotherapy-induced clonal evolution of tumors MK Ibragimova, MM Tsyganov, NV Litviakov Biochemistry (Moscow) 82, 413-425, 2017 | 67* | 2017 |
| Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy NV Litviakov, NV Cherdyntseva, MM Tsyganov, EM Slonimskaya, ... Oncotarget 7 (7), 7829, 2016 | 61* | 2016 |
| The phenomenon of multi-drug resistance in the treatment of malignant tumors SV Vtorushin, KY Khristenko, MV Zavyalova, VM Perelmuter, NV Litviakov, ... Experimental oncology, 2014 | 57 | 2014 |
| Intratumoral morphological heterogeneity of breast cancer as an indicator of the metastatic potential and tumor chemosensitivity TS Gerashchenko, MV Zavyalova, EV Denisov, NV Krakhmal, ... Acta Naturae (англоязычная версия) 9 (1 (32)), 56-67, 2017 | 56* | 2017 |
| Мутации гена ТР53 при раке молочной железы и их взаимосвязь с клинико-патологическими параметрами заболевания ЕВ Денисов, ЕА Малиновская, ЕЮ Гарбуков, НН Бабышкина, ... Сибирский онкологический журнал, 39-40, 2008 | 55* | 2008 |
| Influence of changing pulse repetition frequency on chemical and biological effects induced by low-intensity ultrasound in vitro MA Buldakov, MA Hassan, QL Zhao, LB Feril Jr, N Kudo, T Kondo, ... Ultrasonics sonochemistry 16 (3), 392-397, 2009 | 54 | 2009 |
| Phenotypic Drift as a Cause for Intratumoral Morphological Heterogeneity of Invasive Ductal Breast Carcinoma Not Otherwise Specified MV Zavyalova, EV Denisov, LA Tashireva, TS Gerashchenko, ... BioResearch Open Access, 2013 | 49 | 2013 |
| Cell‐surface‐bound circulating DNA as a prognostic factor in lung cancer SN Tamkovich, NV Litviakov, OE Bryzgunova, AY Dobrodeev, EY Rykova, ... Annals of the New York Academy of Sciences 1137 (1), 214-217, 2008 | 49 | 2008 |
| NF-kB as a potential prognostic marker and a candidate for targeted therapy of cancer KA Gaptulbarova, MM Tsyganov, AM Pevzner, MK Ibragimova, ... Experimental oncology 42 (4), 263-269, 2020 | 47 | 2020 |
| Role of the immune component of tumor microenvironment in the efficiency of cancer treatment: perspectives for the personalized therapy M Stakheyeva, V Riabov, I Mitrofanova, N Litviakov, E Choynzonov, ... Current pharmaceutical design 23 (32), 4807-4826, 2017 | 46 | 2017 |
| Expression of M2 macrophage markers YKL-39 and CCL18 in breast cancer is associated with the effect of neoadjuvant chemotherapy N Litviakov, M Tsyganov, I Larionova, M Ibragimova, I Deryusheva, ... Cancer chemotherapy and pharmacology 82, 99-109, 2018 | 41 | 2018 |
| Invasive and drug resistant expression profile of different morphological structures of breast tumors EV Denisov, TS Gerashchenko, MV Zavyalova, NV Litviakov, ... Neoplasma 62, 3 DOI: 10.4149/neo_2015_041, 2015 | 39 | 2015 |
| Age-related function of tumor suppressor gene TP53: contribution to cancer risk and progression NV Cherdyntseva, PA Gervas, NV Litviakov, MN Stakcheeva, ... Experimental Oncology 32 (3), 205-208, 2010 | 39 | 2010 |
| Разработка магнитоуправляемой системы для доставки химиопрепаратов на основе наноразмерных частиц железа АИ Галанов, ТА Юрмазова, ГГ Савельев, МА Булдаков, ЮВ Рудык, ... Сибирский онкологический журнал, 50-57, 2008 | 39 | 2008 |
| Genome-wide methylotyping resolves breast cancer epigenetic heterogeneity and suggests novel therapeutic perspectives AS Tanas, VO Sigin, AI Kalinkin, NV Litviakov, EM Slonimskaya, ... Epigenomics 11 (6), 605-617, 2019 | 37 | 2019 |
Cherdyntseva Nadezhda V.Cancer Research Institute SB RAMS, Tomsk在 oncology.tomsk.ru 的电子邮件经过验证
